Activist & passive stakes
Investors crossing the 5% ownership line, from SEC Schedule 13D (activist) and 13G (passive) filings. Newest first.
Showing the last 10 days.Sign up free for 90 days
All filings, new and amended.1–8 of 8
- PassiveAmendment 2Oct 30, 2026Vanguard Capital Management5.42% · 22,245,996 shSEC
- PassiveAmendment 2Oct 28, 2026HOLD Alapkezelo Zrt.15.2% · 3,216,097 shSEC
- PassiveAmendment 2Oct 27, 2026BlackRock, Inc.5.2% · 21,121,869 shSEC
- PassiveAmendment 1Below 5%Oct 27, 2026BlackRock, Inc.4.1% · 3,871,884 shSEC
- PassiveAmendment 13Oct 27, 2026BlackRock, Inc.6.9% · 10,988,488 shSEC
- PassiveAmendment 3Oct 27, 2026iShares Environmental Infrastructure and Industrials ETFBlackRock Portfolio Management LLC33.4% · 53,500 shSEC
- PassiveAmendment 3Oct 27, 2026iShares Breakthrough Environmental Solutions ETFBlackRock Portfolio Management LLC43.8% · 70,000 shSEC
- PassiveNewOct 27, 2026BlackRock Portfolio Management LLC5.4% · 1,560,091 shSEC
| Filing | Symbol | Holder | % Owned | Shares | Filed | SEC filing |
|---|---|---|---|---|---|---|
PassiveAmendment 2 | SUNB | Vanguard Capital Management in Sunbelt Rentals Holdings Inc | 5.42% | 22,245,996 | Oct 30, 2026 | SEC |
PassiveAmendment 2 | PESI | HOLD Alapkezelo Zrt. in Perma Fix Environmental Services Inc | 15.2% | 3,216,097 | Oct 28, 2026 | SEC |
PassiveAmendment 2 | SUNB | BlackRock, Inc. in Sunbelt Rentals Holdings, Inc. | 5.2% | 21,121,869 | Oct 27, 2026 | SEC |
PassiveAmendment 1Below 5% | ZNTL | BlackRock, Inc. in Zentalis Pharmaceuticals Inc | 4.1% | 3,871,884 | Oct 27, 2026 | SEC |
PassiveAmendment 13 | PNR | BlackRock, Inc. in Pentair plc | 6.9% | 10,988,488 | Oct 27, 2026 | SEC |
PassiveAmendment 3 | — | BlackRock Portfolio Management LLC in iShares Environmental Infrastructure and Industrials ETF | 33.4% | 53,500 | Oct 27, 2026 | SEC |
PassiveAmendment 3 | — | BlackRock Portfolio Management LLC in iShares Breakthrough Environmental Solutions ETF | 43.8% | 70,000 | Oct 27, 2026 | SEC |
PassiveNew | ENTA | BlackRock Portfolio Management LLC in Enanta Pharmaceuticals Inc | 5.4% | 1,560,091 | Oct 27, 2026 | SEC |